A study of safety and efficacy of novel targeted therapy combinations in adult patients with advanced or metastatic colorectal cancer.
CADPT01C12101
Phase 1 other active
Quick answer
A study of safety and efficacy of novel targeted therapy combinations in adult patients with advanced or metastatic colorectal cancer. for Advanced or metastatic BRAF V600 colorectal cancer. is a Phase 1 program (other) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Advanced or metastatic BRAF V600 colorectal cancer.
- Phase
- Phase 1
- Modality
- other
- Status
- active